Cargando…

Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study

BACKGROUND AND PURPOSE: This nationwide population-based study analyzed the outcomes of local treatment (i.e. stereotactic body radiotherapy [SBRT] or metastasectomy) or systemic therapy for oligometastatic disease (OMD) in patients with esophagogastric cancer in The Netherlands. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kroese, Tiuri E., Jorritsma, Nikita K.N., van Laarhoven, Hanneke W.M., Verhoeven, Rob H.A., Mook, Stella, Haj Mohammad, Nadia, Ruurda, Jelle P., van Rossum, Peter S.N., van Hillegersberg, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523096/ https://www.ncbi.nlm.nih.gov/pubmed/36186924 http://dx.doi.org/10.1016/j.ctro.2022.08.012

Ejemplares similares

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Long-term survival after sequential local treatments for oligometastatic esophageal squamous cell carcinoma: A case report
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy
por: Pape, Marieke, et al.
Publicado: (2023)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Metastasectomy of oligometastatic urothelial cancer: a single-center experience
por: Muilwijk, Tim, et al.
Publicado: (2020)

A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma
por: Pape, Marieke, et al.
Publicado: (2022)

ASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands
por: Pape, Marieke, et al.
Publicado: (2023)

SOURCE beyond first‐line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first‐line palliative systemic therapy
por: Kuijper, Steven C., et al.
Publicado: (2022)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)

Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
por: Ashrafi, Akbar N., et al.
Publicado: (2020)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature
por: ter Veer, Emil, et al.
Publicado: (2016)

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series
por: Palmer, John P., et al.
Publicado: (2023)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

Technical Feasibility of TachoSil Application on Esophageal Anastomoses
por: Haverkamp, Leonie, et al.
Publicado: (2015)

Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review
por: ter Veer, Emil, et al.
Publicado: (2018)

Diagnostic performance of a CT-based scoring system for diagnosis of anastomotic leakage after esophagectomy: comparison with subjective CT assessment
por: Goense, Lucas, et al.
Publicado: (2017)

Robotic-assisted gastrectomy for gastric cancer: a European perspective
por: van Boxel, Gijsbert I., et al.
Publicado: (2019)

Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study
por: Shao, Yi, et al.
Publicado: (2020)

Cervical ultrasonography has no additional value over negative (18)F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer
por: Goense, Lucas, et al.
Publicado: (2017)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study
por: Defize, Ingmar L., et al.
Publicado: (2023)

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer
por: Visser, E., et al.
Publicado: (2016)

Integrating metastasectomy and stereotactic radiosurgery in the treatment of metastatic renal cell carcinoma
por: Bex, Axel
Publicado: (2013)

Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients
por: Klaassen, Remy, et al.
Publicado: (2018)

Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
por: Runkel, Mira, et al.
Publicado: (2021)

Safety and feasibility of minimally invasive surgical interventions for esophageal and gastric cancer in the acute setting: a nationwide cohort study
por: Borggreve, Alicia S., et al.
Publicado: (2020)

Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands
por: Brenkman, H. J. F., et al.
Publicado: (2017)

ASO Author Reflections: Preoperative Selection of cT4b Esophageal Cancer Patients Who Benefit From a Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE)
por: Defize, Ingmar L., et al.
Publicado: (2020)

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
por: Stroes, Charlotte I, et al.
Publicado: (2022)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u89867jfkro3pb0p1t8j8egqno